Review: taking Voltaren and Plavix together


Summary

Drug interactions are reported among people who take Voltaren and Plavix together. This review analyzes the effectiveness and drug interactions between Voltaren and Plavix. It is created by eHealthMe based on reports of 798 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Voltaren

Voltaren has active ingredients of diclofenac sodium. It is often used in rheumatoid arthritis. (latest outcomes from Voltaren 27,863 users)

Plavix

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. (latest outcomes from Plavix 101,521 users)

On Sep, 16, 2016

798 people who take Voltaren, Plavix are studied.


Number of reports submitted per year:

Voltaren and Plavix drug interactions.

Drug effectiveness over time:

Voltaren:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Plavix:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Voltaren:
  • female: 0.0% - (0 of 1 people)
  • male: 50.0% - (1 of 2 people)
Plavix:
  • female: 100.0% - (1 of 1 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Voltaren:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 33.0% - (1 of 3 people)
Plavix:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 66.0% - (2 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • anaemia
  • melaena
  • renal failure acute
  • hypertension
  • haemoglobin decreased
  • hyperkalaemia
  • myocardial infarction
  • rectal haemorrhage
  • angina pectoris
  • neutrophil count decreased
1 - 6 months:
  • gastrointestinal haemorrhage
  • presyncope
  • renal failure acute
  • melaena
  • pyrexia
  • anaemia
  • diverticulum intestinal haemorrhagic
  • drug ineffective
  • epistaxis
  • fatigue
6 - 12 months:
  • anaemia
  • rectal haemorrhage
  • altered state of consciousness
  • arteriosclerosis coronary artery
  • constipation
  • contusion
  • dizziness
  • fatigue
  • haematoma
  • haemorrhage subcutaneous
1 - 2 years:
  • vomiting
  • abdominal pain upper
  • dehydration
  • dyspepsia
  • hepatitis acute
  • abdominal pain
  • colon cancer
  • dizziness
  • fall
  • gastrointestinal pain
2 - 5 years:
  • gastrointestinal haemorrhage
  • anaemia
  • erosive duodenitis
  • gastritis erosive
  • melaena
  • rectal haemorrhage
  • pain
  • anhedonia
  • deformity
  • faeces discoloured
5 - 10 years:
  • anaemia
  • anastomotic ulcer
  • bladder disorder
  • gastrointestinal haemorrhage
  • haemoglobin decreased
  • fall
  • vomiting
  • dizziness
  • gastric ulcer
  • renal impairment
10+ years:
  • contusion
  • faeces discoloured
  • ill-defined disorder
not specified:
  • chest pain
  • anaemia
  • pain
  • nausea
  • cough
  • dyspnoea
  • pain in extremity
  • fatigue
  • dizziness
  • oedema peripheral

Most common drug interactions by gender *:

female:
  • fatigue
  • anaemia
  • chest pain
  • dizziness
  • rectal haemorrhage
  • pain
  • nausea
  • gastrointestinal haemorrhage
  • constipation
  • dyspnoea
male:
  • anaemia
  • chest pain
  • pyrexia
  • confusional state
  • myocardial infarction
  • dizziness
  • drug ineffective
  • pain in extremity
  • pain
  • renal failure acute

Most common drug interactions by age *:

0-1:
  • balance disorder
  • bradycardia
  • cholecystitis chronic
  • convulsion
  • diabetic complication
  • dyspnoea
  • hyponatraemia
  • hypotension
  • nervous system disorder
  • orthopnoea
10-19:
  • diverticulitis
  • nasopharyngitis
  • tuberculin test positive
  • tuberculosis
  • weight decreased
20-29:
  • death
30-39:
  • galactorrhoea
  • constipation
  • diarrhoea
  • nephrogenic systemic fibrosis
  • chest pain
  • loss of consciousness
  • pericardial haemorrhage
  • angina pectoris
  • arthralgia
  • diabetes mellitus
40-49:
  • dyspnoea
  • chest pain
  • coronary artery disease
  • pain
  • weight decreased
  • injury
  • anaemia
  • cerebrovascular accident
  • fatigue
  • cough
50-59:
  • chest pain
  • pain
  • cough
  • nausea
  • injury
  • anxiety
  • anhedonia
  • neuropathy peripheral
  • pain in extremity
  • oedema peripheral
60+:
  • anaemia
  • dizziness
  • fatigue
  • gastrointestinal haemorrhage
  • rectal haemorrhage
  • haematoma
  • altered state of consciousness
  • constipation
  • arteriosclerosis coronary artery
  • contusion

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Voltaren and Plavix?

Can you answer these questions?

More questions for: Voltaren, Plavix

You may be interested in these reviews

More reviews for: Voltaren, Plavix

On eHealthMe, Voltaren (diclofenac sodium) is often used to treat rheumatoid arthritis. Plavix (clopidogrel bisulfate) is often used to treat stent. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.